In the last trading session, 3.21 million shares of the Alkermes plc (NASDAQ:ALKS) were traded, and its beta was 0.46. Most recently the company’s share price was $26.09, and it changed around -$0.76 or -2.83% from the last close, which brings the market valuation of the company to $4.22B. ALKS currently trades at a discount to its 52-week high of $32.88, offering almost -26.03% off that amount. The share price’s 52-week low was $20.46, which indicates that the current value has risen by an impressive 21.58% since then. We note from Alkermes plc’s average daily trading volume that its 10-day average is 2.13 million shares, with the 3-month average coming to 1.72 million.

Alkermes plc stock received a consensus recommendation rating of Hold, based on a mean score of 2.07. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 7 recommended ALKS as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Alkermes plc is expected to report earnings per share of 0.8 for the current quarter.

Alkermes plc (NASDAQ:ALKS) trade information

Instantly ALKS has showed a red trend with a performance of -2.83% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 28.42 on recent trading dayincreased the stock’s daily price by 8.2%. The company’s shares are currently down -5.95% year-to-date, but still down -7.71% over the last five days. On the other hand, Alkermes plc (NASDAQ:ALKS) is -3.97% down in the 30-day period. We can see from the shorts that 15.82 million shares have been sold at a short interest cover period of 8.64 day(s).

The consensus price target as assigned by Wall Street analysts is $35, which translates to bulls needing to increase their stock price by 25.46% from its current value. Analyst projections state that ALKS is forecast to be at a low of $25 and a high of $50.

Alkermes plc (ALKS) estimates and forecasts

Alkermes plc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 5.71 percent over the past six months and at a 14.96% annual growth rate that is well below the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 263.60% in revenue this quarter, and will report an increase of 32.60% in the next quarter. The year-over-year growth rate is expected to be -9.40%, down from the previous year.

Consensus estimates provided by 13 financial analysts predict the company will bring in an average of 380.21M in revenue for the current quarter. 6 analysts expect Alkermes plc to make 325.63M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 377.48M and 350.37M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 0.70%. Forecasts for the next quarter put sales growth at -7.10%.

Alkermes plc earnings are expected to increase by 82.83% in 2024, but the outlook is positive 13.39% per year for the next five years.

ALKS Dividends

Alkermes plc’s next quarterly earnings report is expected to be released in November.

Alkermes plc (NASDAQ:ALKS)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 1.31% of Alkermes plc shares, and 112.23% of them are in the hands of institutional investors. The stock currently has a share float of 113.72%. Alkermes plc stock is held by 462.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 17.3276% of the shares, which is about 29.11 million shares worth $701.49 million.

VANGUARD GROUP INC, with 11.9058% or 20.0 million shares worth $482.0 million as of 2024-06-30, holds the second largest percentage of outstanding shares.